TherapeuticsMD (TXMD) Receivables - Other (2023 - 2025)
TherapeuticsMD's Receivables - Other history spans 7 years, with the latest figure at $3.5 million for Q4 2025.
- For Q4 2025, Receivables - Other fell 81.99% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 81.99%, while the annual FY2025 figure was $3.5 million, 81.99% down from the prior year.
- Receivables - Other reached $3.5 million in Q4 2025 per TXMD's latest filing, down from $3.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $19.6 million in Q4 2024 to a low of $2.9 million in Q2 2024.
- Average Receivables - Other over 3 years is $5.1 million, with a median of $3.3 million recorded in 2024.
- Peak YoY movement for Receivables - Other: surged 533.4% in 2024, then crashed 81.99% in 2025.
- A 3-year view of Receivables - Other shows it stood at $3.1 million in 2023, then soared by 533.4% to $19.6 million in 2024, then plummeted by 81.99% to $3.5 million in 2025.
- Per Business Quant, the three most recent readings for TXMD's Receivables - Other are $3.5 million (Q4 2025), $3.7 million (Q3 2025), and $3.7 million (Q2 2025).